BetterScholar BetterScholar
12
Role
Title
Level Year L/R
🐜 Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
22 auth. Donghyuk Shin, Rukmini Mukherjee, D. Grewe, D. Bojkova, Kheewoong Baek, Anshu Bhattacharya, Laura Schulz, M. Widera, A. Mehdipour, G. Tascher, ... P. Geurink, A. Wilhelm, Gerbrand J. van der Heden van Noort, H. Ovaa, S. Müller, K. Knobeloch, K. Rajalingam, B. Schulman, J. Cinatl, G. Hummer, S. Ciesek, I. Dikič
9 2020
9
🐜
🐜 A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib.
18 auth. D. Chauhan, L. Catley, Guilan Li, K. Podar, T. Hideshima, Mugdha Velankar, C. Mitsiades, N. Mitsiades, H. Yasui, A. Letai, ... H. Ovaa, C. Berkers, B. Nicholson, T. Chao, S. Neuteboom, P. Richardson, M. Palladino, K. Anderson
9 2005
9
🐜
🐜 OTU Deubiquitinases Reveal Mechanisms of Linkage Specificity and Enable Ubiquitin Chain Restriction Analysis
13 auth. T. Mevissen, M. Hospenthal, P. Geurink, P. R. Elliott, M. Akutsu, N. Arnaudo, Reggy Ekkebus, Y. Kulathu, T. Wauer, Farid El Oualid, ... S. Freund, H. Ovaa, D. Komander
9 2013
9
🐜
🐬 Proteome-wide identification of ubiquitin interactions using UbIA-MS
Xiaofei Zhang, A. H. Smits, G. B. van Tilburg, H. Ovaa, W. Huber, M. Vermeulen
9 2018
9
🐬
🐜 Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family.
7 auth. A. Borodovsky, H. Ovaa, Nagamalleswari Kolli, T. Gan-Erdene, K. Wilkinson, H. Ploegh, ... B. Kessler
9 2002
9
🐜
🐒 Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.
M. Groll, C. Berkers, H. Ploegh, H. Ovaa
8 2006
8
🐒
🐜 Mechanism and inhibition of the papain‐like protease, PLpro, of SARS‐CoV‐2
29 auth. T. Klemm, G. Ebert, D. Calleja, C. Allison, L. Richardson, Jonathan P. Bernardini, Bernadine G. C. Lu, Nathan W Kuchel, Christoph Grohmann, Yuri Shibata, Z. Gan, James P. Cooney, M. Doerflinger, A. E. Au, T. Blackmore, ... Gerbrand J. van der Heden van Noort, P. Geurink, H. Ovaa, J. Newman, A. Riboldi-Tunnicliffe, P. Czabotar, Jeffrey P. Mitchell, R. Feltham, B. C. Lechtenberg, K. Lowes, G. Dewson, M. Pellegrini, G. Lessene, D. Komander
8 2020
8
🐜
🐜 Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin
14 auth. Baoxu Pang, Xiaohang Qiao, L. Janssen, A. Velds, T. Groothuis, R. Kerkhoven, Marja Nieuwland, H. Ovaa, S. Rottenberg, O. van Tellingen, ... Jeroen Janssen, P. Huijgens, W. Zwart, J. Neefjes
8 2013
8
🐜
🐜 Design and use of conditional MHC class I ligands
11 auth. M. Toebes, M. Coccoris, A. Bins, B. Rodenko, Raquel Gomez, N. J. Nieuwkoop, ... Willeke van de Kasteele, G. Rimmelzwaan, J. Haanen, H. Ovaa, T. Schumacher
8 2006
8
🐜
🐒 Generation of peptide–MHC class I complexes through UV-mediated ligand exchange
7 auth. B. Rodenko, M. Toebes, S. Hadrup, W. V. Esch, Anne Molenaar, T. Schumacher, ... H. Ovaa
8 2006
8
🐒
🐒 On Terminal Alkynes That Can React with Active-Site Cysteine Nucleophiles in Proteases
12 auth. Reggy Ekkebus, S. V. van Kasteren, Y. Kulathu, A. Scholten, Ilana Berlin, P. Geurink, ... Annemieke de Jong, S. Goerdayal, J. Neefjes, A. Heck, D. Komander, H. Ovaa
8 2013
8
🐒
🐜 Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.
8 auth. Erik Meulmeester, M. Maurice, Chris Boutell, A. Teunisse, H. Ovaa, Tsion E. Abraham, ... R. Dirks, A. Jochemsen
8 2005
8
🐜